Home›People›Jason Camm
JC

Jason Camm

Director at Alloy Therapeutics. Also a director at Angiex.

DirectorRoles at 2 startups
Updated Nov 2, 2026·Latest SEC filing Apr 15, 2026·Suggest an edit

About Jason Camm

Jason Camm is a director at Alloy Therapeutics.

Form D filings also name Jason Camm as a director at Angiex.

Jason Camm first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Jason Camm in the role, so the role may have started earlier or lasted longer.

Alloy Therapeutics, Inc.
Director
2021 – 2026 · Waltham, MA
Drug discovery platforms and development services for biotech companies, pharmaceutical firms and academic researchers.
Angiex, Inc.
Director
2025 · Cambridge, MA

Key Colleagues at Startups

The people Jason Camm works with at each company, as listed on that company's latest Form D.

Alloy Therapeutics, Inc. · Form D, Apr 15, 2026
AS
Anthony Sun
Director
AH
Alaa Halawa
Director
UN
JC
Jason Coloma
Director
AK
Errik Anderson
Errik Anderson
Founder, CEO, Chairman of Alloy
Piotr Bobrowicz
Piotr Bobrowicz
Chief Scientific Advisor and director
LS
Logan Snyder
Director
Angiex, Inc. · Form D/A, Sep 26, 2025
JA
FH
PJ
Paul Jaminet
Chief Executive Officer and director
AA
Amal Amin
Director
HG
Haijing Guo
Director
ID
Iain Dukes
Director
TN
Tina Neel
Director

Sources

  1. SECAlloy Therapeutics, Inc. Form D, filed Apr 15, 2026
  2. SECAngiex, Inc. Form D/A, filed Sep 26, 2025